Skip to content

Freestone Grove Partners LP: CMP position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Freestone Grove Partners LP on CMP, newest first. How the timeline and the estimate are built.

Freestone Grove Partners LP held 4,222 CMP shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 4,222 shares
    Change vs previous 13F -814 shares

    <0.01% of the 13F portfolio, value $131,431.

    13F-HR 0001172661-26-003818 filed by Freestone Grove Partners LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 5,036 shares
    Change vs previous 13F +5,036 shares

    <0.01% of the 13F portfolio, value $117,591.

    13F-HR 0001172661-26-002396 filed by Freestone Grove Partners LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-06-30
    13F 0 shares
    Change vs previous 13F -28,474 shares

    13F-HR 0001172661-25-003528 filed by Freestone Grove Partners LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  4. period ended2025-03-31
    13F 28,474 shares
    Change vs previous 13F +15,221 shares

    <0.01% of the 13F portfolio, value $264,523.

    13F-HR 0001172661-25-002408 filed by Freestone Grove Partners LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-12-31
    13F 13,253 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $149,096.

    13F-HR 0001172661-25-001236 filed by Freestone Grove Partners LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).